285 related articles for article (PubMed ID: 7959190)
1. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants.
Suzuki M; Miura S; Mori M; Kai A; Suzuki H; Fukumura D; Suematsu M; Tsuchiya M
Gut; 1994 Oct; 35(10):1375-8. PubMed ID: 7959190
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori-associated ammonia production enhances neutrophil-dependent gastric mucosal cell injury.
Suzuki M; Miura S; Suematsu M; Fukumura D; Kurose I; Suzuki H; Kai A; Kudoh Y; Ohashi M; Tsuchiya M
Am J Physiol; 1992 Nov; 263(5 Pt 1):G719-25. PubMed ID: 1443147
[TBL] [Abstract][Full Text] [Related]
3. [Role of ammonia-monochloramine system in Helicobacter pylori--induced gastric mucosal injury].
Suzuki M; Miura S
Nihon Rinsho; 1993 Dec; 51(12):3154-8. PubMed ID: 8283624
[TBL] [Abstract][Full Text] [Related]
4. Nonopsonic activation of neutrophils by Helicobacter pylori is inhibited by rebamipide.
Danielsson D; Jurstrand M
Dig Dis Sci; 1998 Sep; 43(9 Suppl):167S-173S. PubMed ID: 9753245
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of rebamipide on the neutrophil adherence stimulated by conditioned media from Helicobacter pylori-infected gastric epithelial cells.
Kim CD; Kim HH; Hong KW
J Pharmacol Exp Ther; 1999 Jan; 288(1):133-8. PubMed ID: 9862763
[TBL] [Abstract][Full Text] [Related]
6. The antioxidant effect of rebamipide on oxygen free radical production by H. pylori-activated human neutrophils: in comparison with N-acetylcysteine, ascorbic acid and glutathione.
Hong WS; Jung HY; Yang SK; Myung SJ; Kim JH; Min YI; Chung MH; Lee HS; Kim HW
Pharmacol Res; 2001 Oct; 44(4):293-7. PubMed ID: 11592863
[TBL] [Abstract][Full Text] [Related]
7. Rebamipide protects against activation of neutrophils by Helicobacter pylori.
Yoshida N; Yoshikawa T; Iinuma S; Arai M; Takenaka S; Sakamoto K; Miyajima T; Nakamura Y; Yagi N; Naito Y; Mukai F; Kondo M
Dig Dis Sci; 1996 Jun; 41(6):1139-44. PubMed ID: 8654144
[TBL] [Abstract][Full Text] [Related]
8. Effect of rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells.
Hayashi S; Sugiyama T; Amano K; Isogai H; Isogai E; Aihara M; Kikuchi M; Asaka M; Yokota K; Oguma K; Fujii N; Hirai Y
Antimicrob Agents Chemother; 1998 Aug; 42(8):1895-9. PubMed ID: 9687380
[TBL] [Abstract][Full Text] [Related]
9. Effects of rebamipide on gastric cell damage by Helicobacter pylori-stimulated human neutrophils.
Han BG; Kim HS; Rhee KH; Han HS; Chung MH
Pharmacol Res; 1995 Oct; 32(4):201-7. PubMed ID: 8866835
[TBL] [Abstract][Full Text] [Related]
10. In vitro studies indicating antioxidative properties of rebamipide.
Iinuma S; Naito Y; Yoshikawa T; Takahashi S; Takemura T; Yoshida N; Kondo M
Dig Dis Sci; 1998 Sep; 43(9 Suppl):35S-39S. PubMed ID: 9753224
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of lipid peroxidation, NF-kappaB activation and IL-8 production by rebamipide in Helicobacter pylori-stimulated gastric epithelial cells.
Kim H; Seo JY; Kim KH
Dig Dis Sci; 2000 Mar; 45(3):621-8. PubMed ID: 10749342
[TBL] [Abstract][Full Text] [Related]
12. Rebamipide inhibits ceramide-induced interleukin-8 production in Kato III human gastric cancer cells.
Masamune A; Yoshida M; Sakai Y; Shimosegawa T
J Pharmacol Exp Ther; 2001 Aug; 298(2):485-92. PubMed ID: 11454909
[TBL] [Abstract][Full Text] [Related]
13. Preventive effect of rebamipide on gastric mucosal cell damage evoked by activation of formyl-methionyl-leucyl-phenylalanine receptors of rabbit neutrophils.
Kim CD; Hong KW
J Pharmacol Exp Ther; 1997 Apr; 281(1):478-83. PubMed ID: 9103534
[TBL] [Abstract][Full Text] [Related]
14. The effect of rebamipide on the expression of proinflammatory mediators and apoptosis in human neutrophils by Helicobacter pylori water-soluble surface proteins.
Kim JS; Kim JM; Jung HC; Song IS
Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():45-54. PubMed ID: 12925140
[TBL] [Abstract][Full Text] [Related]
15. Role of rebamipide on induction of heat-shock proteins and protection against reactive oxygen metabolite-mediated cell damage in cultured gastric mucosal cells.
Hahm KB; Park IS; Kim YS; Kim JH; Cho SW; Lee SI; Youn JK
Free Radic Biol Med; 1997; 22(4):711-6. PubMed ID: 9013134
[TBL] [Abstract][Full Text] [Related]
16. Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats.
Ogino K; Hobara T; Ishiyama H; Yamasaki K; Kobayashi H; Izumi Y; Oka S
Eur J Pharmacol; 1992 Feb; 212(1):9-13. PubMed ID: 1313372
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of attenuating effects of rebamipide, an anti-ulcer agent, on oxidative burst of human neutrophils.
Shimoyama T; Fukuda S; Liu Q; Fukuda Y; Nakaji S; Sugawara K
J Pharmacol Sci; 2003 Feb; 91(2):153-7. PubMed ID: 12686760
[TBL] [Abstract][Full Text] [Related]
18. Effect of rebamipide on H. pylori-associated gastric mucosal injury in Mongolian gerbils.
Suzuki H; Mori M; Kai A; Suzuki M; Suematsu M; Miura S; Ishii H
Dig Dis Sci; 1998 Sep; 43(9 Suppl):181S-187S. PubMed ID: 9753247
[TBL] [Abstract][Full Text] [Related]
19. Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophils in rats.
Murakami K; Okajima K; Harada N; Isobe H; Okabe H
Dig Dis Sci; 1998 Sep; 43(9 Suppl):139S-142S. PubMed ID: 9753240
[TBL] [Abstract][Full Text] [Related]
20. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing.
Arakawa T; Kobayashi K; Yoshikawa T; Tarnawski A
Dig Dis Sci; 1998 Sep; 43(9 Suppl):5S-13S. PubMed ID: 9753220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
